Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
SWOG S0777 trial: lenalidomide, dexamethasone and bortezomib for the treatment of MM
What to look for in novel CLL therapies
Which is the best combination therapy in relapsed and refractory multiple myeloma?
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?